Ridaura and Seldane patent extensions
Executive Summary
FDA has granted SmithKline and Merrell Dow two-year patent extensions for Ridaura and Seldane, respectively, in March 11 letters to the companies. Ridaura's patent was originally issued on Jan. 2, 1973 and Seldane's on April 15, 1975